Alpha males are rare among our fellow primates: scientists
"For a long time we have had a completely binary view of this issue: we thought that a species was either dominated by males or females -- and that this was a fixed trait," Elise Huchard, a primatologist at the University of Montpellier in France, told AFP.
"Recently, this idea has been challenged by studies showing that the truth is much more complicated," said the lead author of a new study published in the journal PNAS.
The French-German team of researchers combed through scientific literature for interactions between male and female primates that revealed their hierarchical relationships.
These included aggression, threats and signs of dominant or submissive behaviour, such as when one primate spontaneously moved out of the way of another.
Over five years, the team gathered data from 253 populations across 121 primate species, including a range of monkeys, lemurs, tarsiers and lorises.
They found that confrontations between members of the opposite sex were much more frequent than had been previously thought. On average, more than half of these interactions within a group involved a male and a female.
Males clearly dominating females, which was defined as winning more than 90 percent of these confrontations, was only observed in 17 percent of the populations. Among this minority were baboons and chimpanzees, which are the closest living relatives to humans.
Clear female domination was recorded in 13 percent of the primate populations, including lemurs and bonobos.
This meant that for 70 percent of the primates, either males or females could be at the top of the pecking order.
- Battle of the sexes -
When male domination was particularly pronounced, it was usually in a species where males have a clear physical advantage, such as bigger bodies or teeth.
It was also more common among ground-bound species, in which females are less able to run and hide compared to their relatives living in the trees.
Females, meanwhile, tended to dominate over societies when they exerted control over reproduction.
For example, the genitals of female baboons swell when they are ovulating. Males jealously guard females during these few days of their menstrual cycle, making sure that other competitors cannot mate with them.
However in bonobos, this sexual swelling is less obvious.
"Males never know when they are ovulating or not. As a result, (the female bonobos) can mate with whoever they want, whenever they want, much more easily," Huchard said.
Female dominance is also more common when females compete with each other, and when males provide more care for the young.
In these species, females are often solitary or only live in male-female pairs. This means that monogamy is closely linked to female dominance.
Can these results be extrapolated to our own species? There are a great many differences between humans and our fellow primates, Huchard emphasised.
But we would broadly fall into the middle category in which neither males nor females always have strict dominance over the other.
"These results corroborate quite well with what we know about male-female relationships among hunter-gatherers, which were more egalitarian than in the agricultural societies that emerged later" in human history, Huchard said.
ber/dl/giv
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Volunteers use DNA tech, AI to find fishermen lost at sea decades ago
Jan van den Berg stares out at the sea where his father vanished seven decades ago — lost in a storm just days before his birth. Now aged 70, he clings to the hope of finding even the smallest fragment of his father's remains. In Urk, a fishing village in the northern Netherlands, the sea has long been the lifeblood for families — but has often taken loved ones in return. Some bodies never surfaced. Others washed ashore on German or Danish coasts and were buried in unnamed graves. Despite the tragedy, Van den Berg — the last of six children — became a fisherman like his brothers, defying their mother's terror that the North Sea would claim her sons too. "We never found his body," he told AFP in a low voice, mumbling under the brim of his hat. But after decades of uncertainty, advances in DNA technology and artificial intelligence have given Van den Berg renewed hope. Researchers are now able to match remains with living relatives more accurately than ever before, offering families long-awaited answers and the chance to finally mourn properly. "Many families still gaze at the front door, hoping their loved-one will walk through it," said Teun Hakvoort, an Urk resident who serves as spokesperson for a new foundation dedicated to locating and identifying fishermen lost at sea. "All sunken boats have been mapped. Using modern tech, we look at the weather and currents at the time of the shipwreck to estimate where the fishermen might have washed ashore," the 60-year-old said. Man missing for 47 years returned to family The foundation, Identiteit Gezocht (Identity Sought), aims to list all unknown graves on the coasts of the North Sea, hoping to identify remains. The new searches have already borne fruit. A body was recently exhumed on Schiermonnikoog, a small island north of the Netherlands, and returned to the family. "This man had been missing for 47 years. After all this time, DNA and this new method of work made it possible to discover he came from Urk," said Hakvoort. Another Hakvoort, Frans Hakvoort, leads the foundation with the support of his two brothers in Urk, a tight-knit Protestant community where certain family names frequently reoccur. The three men, who have all lost a relative at sea, dedicate their free time to searching for the missing. "With AI, we search for press articles published after a body washed ashore, possibly in specific circumstances," said Frans Hakvoort, 44. "We enter all this information into a database to see if we can establish a link. If so, we contact local authorities to see if they can exhume the body." The Netherlands leads other North Sea countries in identifying the missing, he said, with about 90 percent of unknown bodies exhumed and all DNA profiles stored in a European database. Given the usual fishing areas and prevailing currents, Urk fishermen are more likely to be buried on German or Danish coasts, he said. The foundation has called on the public to help identify unknown graves in Germany and Denmark. "Denmark and Germany in particular are of great importance at the moment, because we expect that relatively many fishermen have washed ashore there. All help is welcome, we also want to appeal to holidaymakers," Frans Hakvoort told the Het Ukerland newspaper. The foundation works mainly with volunteers and has to make do with money from donors and sponsors. Hakvoort told NOS that recently one member of the public donated 5,000 euros to the cause. "It remains an open wound" Jan van den Berg runs his fingers over his father's name, engraved on a monument overlooking Urk beach to honour lost fishermen. The list is long. More than 300 names — fathers, brothers, and sons, with dates stretching back to the 18th century. Among the names are about 30 fishermen never found. Kees Korf, missing since 1997, aged 19. Americo Martins, 47, in 2015. A statue of a woman, her back turned to the sea, represents all these mothers and wives hoping their loved-one returns. "My father disappeared during a storm on a freezing October night in 1954," says Van den Berg. "One morning he left the port heading for the North Sea. He was not supposed to be gone long because I was about to be born." His uncle, who was also aboard, later said his father was on deck when wild waves flipped the boat over. The tragedy still haunts the family to this day. "When they pulled the nets on deck with fish, my older brothers always feared there might be something that looked like a human," Van den Berg said. In 1976, his uncle's boat disappeared with two of his cousins, aged 15 and 17, also on board. He was among those who found the body of Jan Jurie, the eldest, four months later. The others were never found. "Not a day goes by without thinking of them, all those men, and that is why I take part in the searches and give my DNA, because it remains an open wound," he said. "I would like to have at least a small bone of my father to place in my mother's grave." Sneak peek: Who Killed Aileen Seiden in Room 15? Everything we know so far about the deadly Texas floods Search continues for dozens after Texas floods, at least 79 dead with more severe weather expected
Yahoo
7 hours ago
- Yahoo
Alpha males are rare among our fellow primates: scientists
New research on Monday contradicted the commonly held idea that males dominate females among primates, revealing far more nuanced power dynamics in the relationships of our close relatives. "For a long time we have had a completely binary view of this issue: we thought that a species was either dominated by males or females -- and that this was a fixed trait," Elise Huchard, a primatologist at the University of Montpellier in France, told AFP. "Recently, this idea has been challenged by studies showing that the truth is much more complicated," said the lead author of a new study published in the journal PNAS. The French-German team of researchers combed through scientific literature for interactions between male and female primates that revealed their hierarchical relationships. These included aggression, threats and signs of dominant or submissive behaviour, such as when one primate spontaneously moved out of the way of another. Over five years, the team gathered data from 253 populations across 121 primate species, including a range of monkeys, lemurs, tarsiers and lorises. They found that confrontations between members of the opposite sex were much more frequent than had been previously thought. On average, more than half of these interactions within a group involved a male and a female. Males clearly dominating females, which was defined as winning more than 90 percent of these confrontations, was only observed in 17 percent of the populations. Among this minority were baboons and chimpanzees, which are the closest living relatives to humans. Clear female domination was recorded in 13 percent of the primate populations, including lemurs and bonobos. This meant that for 70 percent of the primates, either males or females could be at the top of the pecking order. - Battle of the sexes - When male domination was particularly pronounced, it was usually in a species where males have a clear physical advantage, such as bigger bodies or teeth. It was also more common among ground-bound species, in which females are less able to run and hide compared to their relatives living in the trees. Females, meanwhile, tended to dominate over societies when they exerted control over reproduction. For example, the genitals of female baboons swell when they are ovulating. Males jealously guard females during these few days of their menstrual cycle, making sure that other competitors cannot mate with them. However in bonobos, this sexual swelling is less obvious. "Males never know when they are ovulating or not. As a result, (the female bonobos) can mate with whoever they want, whenever they want, much more easily," Huchard said. Female dominance is also more common when females compete with each other, and when males provide more care for the young. In these species, females are often solitary or only live in male-female pairs. This means that monogamy is closely linked to female dominance. Can these results be extrapolated to our own species? There are a great many differences between humans and our fellow primates, Huchard emphasised. But we would broadly fall into the middle category in which neither males nor females always have strict dominance over the other. "These results corroborate quite well with what we know about male-female relationships among hunter-gatherers, which were more egalitarian than in the agricultural societies that emerged later" in human history, Huchard said. ber/dl/giv
Yahoo
7 hours ago
- Yahoo
The $20 Million Bet on CRISPR to Cure Rare Childhood Diseases
Jennifer Doudna, Priscilla Chan Zuckerberg Credit - David Paul Morris—Bloomberg/Getty Images; Suzanne Cordeiro—AFP/Getty Images Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to appear soon after birth. To date, there haven't been many reliable treatment options for these babies. The few that do exist involve invasive and risky procedures that don't often have a high rate of success. But there is a new source of hope for many of these families: the Center for Pediatric CRISPR Cures at the University of California San Francisco. The center—plans for which were announced July 8—is a collaboration between Jennifer Doudna, director of the Innovative Genomics Institute at the University of California, Berkeley who also earned the Nobel Prize for her work in co-discovering the gene-editing technique CRISPR, and Dr. Priscilla Chan, co-CEO and co-founder of the Chan Zuckerberg Initiative. Supported by $20 million from the Chan Zuckerberg Initiative, the center focuses on treating rare genetic diseases in children, starting with a group of eight kids who will enroll in a clinical trial to access a CRISPR therapy designed specifically for them. Doctors and researchers, including Chan and Doudna, believe that CRISPR can be used to change and correct a range of genetic mutations and scaled up to help more patients. And the medical teams plan to start enrolling patients immediately. "We want to ensure that CRISPR-based therapies become widely available, especially for rare diseases that likely won't be the target for pharmaceutical companies," Doudna tells TIME. Read More: The 4 Words That Drive Your Doctor Up the Wall The partnership was inspired by the recent success in treating KJ Muldoon, the first baby to receive a customized CRISPR treatment. KJ was born at the Children's Hospital of Philadelphia with a rare genetic disease that prevents him from breaking down proteins properly. The therapy, called base-editing, replaced a faulty letter in KJ's DNA with the correct one that now lets him eat some protein. KJ's treatment represents the next phase of CRISPR-based therapies. While CRISPR treatments have been approved by the FDA to treat sickle cell disease and certain types of beta thalassemia, those therapies involve removing cells from patients, editing them with CRISPR to correct the genetic defect, and then infusing those cells back to the patients. In KJ's case, the CRISPR editing occurred in his own body, via three injections of a therapy developed just for him. That's the same model that the new center will use. 'With that story, there was a lot of momentum within our teams about whether we could do that again, and how we could learn from this to create a pipeline to reduce cost and make this therapy much more widely available,' Doudna says. Doudna thought of Chan, whose initiative has the mission of curing, preventing, or treating all diseases by the end of the century. It was an ideal match, since Chan had trained as a pediatrician at the University of California San Francisco and spent eight years treating children with rare genetic diseases after finishing medical school. 'When Jennifer called me, I thought, 'This is perfect,'' Chan tells TIME. She recalls encountering families whose babies were affected by diseases so rare that there was often little, if any, information about them. 'I have seared in my mind the image of a parent handing me a PDF that they carried around to explain to each resident that this is what we have, and this is all that we know about it. I carry that around daily.' The experience inspired her to create the Rare As One program at the Chan Zuckerberg Initiative, a network of patients, researchers, and scientists from different disciplines that highlights the need for basic research needed to better understand these conditions in order to develop more effective treatments for them. Read More: The Surprising Reason Rural Hospitals Are Closing CRISPR, with its ability to target specific genetic mutations, holds the most promise for changing the course of such diseases. But time is of the essence. In KJ's case, the entire process of identifying his mutation, developing the treatment, testing it, and receiving FDA clearance took nine months. KJ was just six months old when he received his first CRISPR treatment. Acting that quickly is critical for conditions like these, since once cells or organs are damaged by disease-causing mutations, they can't always be rescued. The idea is to intervene with a CRISPR therapy to minimize the effects that the mutations could have. Currently, about 6,000 rare diseases affect 300 million people worldwide, and 72% of them are linked to genetic aberrations. A similar proportion primarily affect children. The new center will focus on identifying disease-causing mutations that can easily be targeted—such as in the liver, as in KJ's case. 'Jennifer and her team, and the team at UCSF, will be very careful in choosing mutations that are amenable to this treatment,' says Chan. 'Not all mutations will work well with this version of there will be a delicate balance in choosing patients who stand to benefit the most in this situation.' Patients will join a clinical trial to receive the treatment, and the research team will study them to learn from their experiences and continue to improve the treatment and the process. Read More: Why It's So Hard to Have Your Fertility Tested In the first cases that the center will try to treat, the FDA will consider each treatment on its own and decide whether to approve the customized therapy for that particular patient. But, says Doudna, 'as we continue to get more information on the safety and potential risks of CRISPR for different indications, what is emerging is the potential to designate CRISPR as a platform technology.' That means that if regulators approve the framework of the CRISPR gene-editing process, doctors would not need to conduct animal tests for each new CRISPR therapy designed for a patient. The only thing that would change would be the guide RNA, Doudna says, which carries the genetic instructions for finding the specific mutation that needs to be addressed. 'Even there, most of the guide RNA stays the same, and it's just the piece at the end providing the molecular zip code that changes.' Key to making that happen will be advances in other scientific areas, including using AI to predict how changing specific genes will affect a cell's function and what potential health outcomes a CRISPR-based treatment might have. That work is ongoing separately at places like Chan Zuckerberg Initiative and elsewhere, says Chan. Eventually, says Doudna, 'we hope as the process moves forward, it will be possible to both predict clinical outcomes of CRISPR therapies accurately and ensure that by changing just a little part of the guide RNA, everything else will remain the same, so you don't have to do full-blown animal testing for every single iteration of CRISPR. If that becomes possible, then it will make CRISPR a lot cheaper and a lot faster to test these kinds of therapies.' That would make it available for many more patients as well. Contact us at letters@
